Lixte Biotechnology Holdings Inc share price logo

Lixte Biotechnology Holdings Inc Share Price

NASDAQ: LIXT

Small Cap

$2.78

+0.12

(+4.51%)

as on

Lixte Biotechnology Holdings Inc Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.60
    $2.80
    downward going graph

    6.47%

    Downside

    0.72%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.64
    $6.26
    downward going graph

    76.98%

    Downside

    125.18%

    Upside

    downward going graph

Lixte Biotechnology Holdings Inc share price movements today

Previous Close
$2.66
Open
$2.65
Volume
253.8K
Day's Low - High
$2.60 - $2.80
52 Week Low - High
$0.64 - $6.26

Lixte Biotechnology Holdings Inc Historical Returns

1 Month Return
-12.5 %
3 Month Return
-34.32 %
1 Year Return
+ 97.04 %
3 Year Return
-68.77 %
5 Year Return
-92.06 %

Lixte Biotechnology Holdings Inc Stock Fundamentals & Key Indicators

Check Lixte Biotechnology Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.8M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-130.06%

Lixte Biotechnology Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lixte Biotechnology Holdings Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Lixte Biotechnology Holdings Inc image
Lixte Biotechnology Holdings Inc
NA$23.8M-92.06%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for Lixte Biotechnology Holdings Inc Stock including INR - Dollar returns

The Lixte Biotechnology Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Lixte Biotechnology Holdings Inc investment value today

Current value as on today

₹2,15,467

Returns

₹1,15,467

(+115.47%)

Returns from Lixte Biotechnology Holdings Inc Stock

₹1,05,926 (+105.93%)

Dollar Returns*

₹9,541 (+9.54%)

Lixte Biotechnology Holdings Inc Stock’s Investor Sentiment and Interest

Search interest for Lixte Biotechnology Holdings Inc Stock has increased by 92% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:92% versus previous 30 day period

Lixte Biotechnology Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-1
-1
-1
0
-1
0
0
0
0
-1
EBITDA
-1
-1
-1
0
-1
0
-1
0
0
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-1
-1
-1
0
-1
0
0
0
0
-2
Income Tax Expense
0
0
0
0
-
0
0
-
-
-
Net Income
-1
-1
-1
0
-1
0
0
0
0
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Lixte Biotechnology Holdings Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
-
-
-
-
-
-
-
Operating Income
-2
-2
-1
-2
-2
-3
-6
-6
-5
-3
EBITDA
-2
-2
-1
-2
-2
-3
-6
-6
-5
-3
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-2
-2
-1
-2
-2
-3
-6
-6
-5
-3
Income Tax Expense
0
0
0
0
0
0
0
0
0
-
Net Income
-2
-2
-1
-2
-2
-3
-6
-6
-5
-3
Net Profit Margin
-1426.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Lixte Biotechnology Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-1
-1
0
-1
0
0
0
0
-1
Operating Cash Flow
0
0
0
0
0
0
0
0
0
Investing Cash Flow
-
3
-
-
-
-
0
-
-2
Financing Cash Flow
3
-
-
-
-
-
0
0
5
Change in Cash
2
0
0
0
0
0
0
0
2

Lixte Biotechnology Holdings Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-2
-1
-2
-2
-3
-6
-6
-5
-3
Operating Cash Flow
-1
-1
-1
-1
-2
-4
-4
-4
-3
Investing Cash Flow
0
-
-
-
-
-
5
-
-
Financing Cash Flow
1
2
4
4
4
3
5
3
-
Change in Cash
0
1
2
-1
2
0
0
-1
-3

Global Institutional Holdings in Lixte Biotechnology Holdings Inc

Funds
Holdings
Clear Street Group Inc
0%
Advisor Group Holdings, Inc.
0.04%
CLEAR STREET LLC.
0%
Scotia Capital Inc
2.97%
Tower Research Capital LLC
0.01%
See all

Insights on Lixte Biotechnology Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, LIXT stock has moved up by 97.0%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LIXT has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lixte Biotechnology Holdings Inc has experienced a drawdown of -68.8%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 58.6%

About Lixte Biotechnology Holdings Inc

lixte biotechnology holdings, inc. (lixte) is a clinical-stage public (lixt) pharmaceutical company dedicated to discovering drugs for more effective treatments for cancer. lixte has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. the current drug portfolio includes inhibitors of protein phosphatases that are critical to cell division and dna damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation. the phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general as well as radiation therapy making them potentially useful for the treatment of many, if not all, cancers in combination with existing standard chemotherapy regimens and the evolving targeted cytotoxic therapies of personalized cancer medicine. the lead compound lb-100 is in phase i trial and has the potential to be first-in-class. the deacetylase in
OrganisationLixte Biotechnology Holdings Inc
Headquarters680 East Colorado Boulevard, Pasadena, CA, United States, 91101
IndustryBiotechnology
CEOMr. Geordan G. Pursglove
E-voting on sharesClick here to vote

Key Management of Lixte Biotechnology Holdings Inc

Name

Title

Mr. Bastiaan van der Baan M.Sc.

Chief Scientific Officer

Mr. Geordan G. Pursglove

CEO, President & Chairman

Mr. Peter M. Stazzone

Chief Financial Officer

FAQs

What is Lixte Biotechnology Holdings Inc share price today?

Lixte Biotechnology Holdings Inc share price today is $2.78 as on at the close of the market. Lixte Biotechnology Holdings Inc share today touched a day high of $2.8 and a low of $2.6.

What is the 52 week high and 52 week low for Lixte Biotechnology Holdings Inc share?

Lixte Biotechnology Holdings Inc share touched a 52 week high of $6.26 on and a 52 week low of $0.64 on . Lixte Biotechnology Holdings Inc stock price today i.e. is closed at $2.78,which is 55.59% down from its 52 week high and 334.37% up from its 52 week low.

What is Lixte Biotechnology Holdings Inc's market capitalisation today?

Lixte Biotechnology Holdings Inc market capitalisation is $0.00T as on .

How to invest in Lixte Biotechnology Holdings Inc Stock (LIXT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lixte Biotechnology Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lixte Biotechnology Holdings Inc Shares that will get you 0.5396 shares as per Lixte Biotechnology Holdings Inc share price of $2.78 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Lixte Biotechnology Holdings Inc Stock (LIXT) from India?

Indian investors can start investing in Lixte Biotechnology Holdings Inc (LIXT) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Lixte Biotechnology Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Lixte Biotechnology Holdings Inc share’s latest price of $2.78 as on March 25, 2026 at 1:29 am IST, you will get 3.5971 shares of Lixte Biotechnology Holdings Inc. Learn more about fractional shares .

What are the returns that Lixte Biotechnology Holdings Inc has given to Indian investors in the last 5 years?

Lixte Biotechnology Holdings Inc stock has given -92.06% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?